CollaGenex Pharmaceuticals


Feb 09, 01

17:24 ET CollaGenex Pharmaceuticals, Inc. Announces Fourth Quarter 2000 Conference Call

 
Mar 16, 98

16:22 ET CollaGenex, FDA Agree on Action Plan for Review of Periostat(R) NDA

 
Feb 24, 98

09:04 ET CollaGenex Pharmaceuticals, Inc. Announces Fourth Quarter And Full-Year 1997 Results

 
Jan 28, 98

16:00 ET CollaGenex Pharmaceuticals Receives Second FDA Action Letter on Periostat(R)

 
Jan 12, 98

16:30 ET CollaGenex Announces Positive New Periostat Clinical Trial Results

 
Dec 05, 97

07:59 ET NCI Files IND For First CollaGenex Cancer Drug

 
Nov 12, 97

11:44 ET CollaGenex Technology Featured at International Symposium

 
Nov 05, 97

09:06 ET Collagenex Pharmaceuticals to Collaborate With Heska To Develop Drugs for Animal Health

 
08:00 ET Heska Enters Development Collaboration With CollaGenex for Pharmaceutical Products for Treatment of Inflammatory Diseases

 
Oct 21, 97

10:23 ET CollaGenex Pharmaceuticals, Inc. Announces Third Quarter Results

 
Sep 16, 97

16:00 ET CollaGenex Pharmaceuticals Adopts Shareholder Rights Plan

 
Sep 02, 97

08:06 ET CollaGenex Pharmaceuticals Receives First FDA Action Letter on Periostat

 
Jul 21, 97

15:45 ET CollaGenex Pharmaceuticals, Inc. Announces Second Quarter Results

 
12:17 ET Periostat(R) Marketing Authorization for Approval Filed in Italy

 
Jun 30, 97

09:01 ET National Cancer Institute Extends Collaboration with CollaGenex Pharmaceuticals, Inc.

 
Jun 03, 97

09:36 ET CollaGenex Pharmaceuticals Hires V.P. of Sales and V.P. of Marketing

 
May 12, 97

09:01 ET CollaGenex Pharmaceuticals Launches First Product and Sales Force

 
May 05, 97

11:59 ET CollaGenex Pharmaceuticals, Inc. Announces First Quarter Results

 
Apr 16, 97

12:15 ET CollaGenex Pharmaceuticals Elects Peter R. Barnett to Board of Directors

 
Apr 03, 97

14:29 ET CollaGenex Pharmaceuticals Completes Public Offering of 1,000,000 Shares Of Common Stock at $12.50 Per Share

 


Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.
Terms and conditions, including restrictions on redistribution, apply.
Copyright © 1996-2005 PR Newswire Association LLC. ALL Rights Reserved.
A United Business Media company.